Categories Uncategorized

Earth Science Tech, Inc. (ETST) Sees Uplisting to OTCQB Venture Market as Key to Goal of being Global Leader in Cannabinoid Market

  • Biotech company is focused on becoming a worldwide leader in R&D and sale of hemp-derived, CBD-based nutraceuticals, pharmaceuticals and dietary supplements
  • ETST is developing three new CBD formulas in Canada under a provisory patent; it is also clinical testing its Hygee medical device for detecting sexually transmitted diseases in women
  • With its Form 10 Registration Statement filing now effective, ETST will begin reporting annual, quarterly and periodic financial statements

Earth Science Tech, Inc. (OTCQB: ETST) anticipates that its uplisting to the OTCQB Venture Market will enable it to reach global recognition and increase liquidity as a leader in the hemp-based CBD space in several fields, such as cannabinoid products. It also develops innovative medical devices designed for multi-national marketing (http://cnw.fm/aUZj5).

The Florida-based company seeks to raise its recognition level and perform more R&D for the CBD industry. ETST manufactures, markets and distributes its own cannabinoid products, including capsules and oils. It is a leader in the medical cannabis markets, with its products available at retail health food stores and e-liquid smoke shops.

“Historically, up-listing to the OTCQB and being fully reporting has resulted in greater liquidity and awareness,” Nickolas S. Tabraue, president, director and chairman of ETST, stated in a news release (http://cnw.fm/Z2OIr). “We are committed to the higher level of corporate and financial disclosures required as an OTCQB fully reporting company, demonstrating our commitment to our loyal shareholders.”

In Canada, it is testing three new CBD IP formulations. It is also clinical testing its Hygee MSN-2 medical device for detection of sexually transmitted infections (STIs) in women at Québec’s Clinique Santé Amitié (http://cnw.fm/p0L4I).

It is developing two new products in Brazil in a joint venture with Bionatus Laboratrio Botnico of Brazil and its Canadian division Bionatus Botanical Laboratories, Inc. In the U.S., it is conducting studies with the University of Central Oklahoma on the impact of high grade full spectrum CBD on immune cells and breast cancer (http://cnw.fm/Ti0j6).

ETST holds several wholly owned subsidiaries. Cannabis Therapeutics is an emerging biotechnology company. KannaBidioiD manufactures and distributes in the recreational sector. Earth Science Foundation, Inc. is becoming a non-profit and accepts grants and donations to conduct additional studies. Earth Science Pharmaceutical develops medical diagnostic tools and vaccines. It also formed subsidiary Canno Inno Laboratories Inc., a strategic Montreal, Canada-based company that provides ETST with access to government grants.

For more information, visit the company’s website at www.EarthScienceTech.com

More from CannabisNewsWire

About HempWire

HempWire (HW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) HempNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, HW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. HW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, HW brings its clients unparalleled visibility, recognition and brand awareness. HW is where news, content and information converge.

To receive instant SMS alerts, text HEMPWIRE to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.hempwire.com

Please see full terms of use and disclaimers on the HempWire website applicable to all content provided by HW, wherever published or re-published: https://www.hempwire.com/disclaimer/

HempWire (HW)
Denver, Colorado
www.hempwire.com
303.498.7722 Office
Editor@HempWire.net

Chris@HW

Share
Published by
Chris@HW

Recent Posts

Restrictions, State Bans Threaten the Thriving Market for Hemp-Sourced Intoxicants

Legislators in states across the country are working towards strictly regulating and/or banning intoxicating hemp…

4 weeks ago

Senate Panel in Florida Starts Discussing Bill Restricting Hemp Products

A proposal introduced by Sen. Colleen Burton that would ban delta-8 THC hemp products is…

4 weeks ago

California Extends Prohibition of Hemp Products with THC

California recently extended a ban on intoxicating hemp products with THC that was set to…

1 month ago

Poll Finds More Consumers Want to Use Hemp Delivery Services

A new poll has determined that frequent consumers of marijuana like using delivery platforms to…

1 month ago

Hemp Seeds Are Attracting Attention as an Alternative Source of Protein

The demand for plant-based proteins has increased in the last couple of years as consumer…

1 month ago

UK Approves 5 CBD Applications, Doubles Down on 10mg Cap

The CBD market in the United Kingdom has grown since the compound’s extracts were designated…

1 month ago